title: Expression profiling pre-diabetic mice to uncover drugs with clinical application to type 1 diabetes.
abstract: In the NOD mouse model of type 1 diabetes (T1D), genetically identical mice in the same environment develop diabetes at different rates. Similar heterogeneity in the rate of progression to T1D exists in humans, but the underlying mechanisms are unclear. Here, we aimed to discover peripheral blood (PB) genes in NOD mice predicting insulitis severity and rate of progression to diabetes. We then wished to use these genes to mine existing databases to identify drugs effective in diabetes. In a longitudinal study, we analyzed gene expression in PB samples from NOD.CD45.2 mice at 10 weeks of age, then scored pancreatic insulitis at 14 weeks or determined age of diabetes onset. In a multilinear regression model, Tnf and Tgfb mRNA expression in PB predicted insulitis score (R (2)=0.56, P=0.01). Expression of these genes did not predict age of diabetes onset. However, by expression-profiling PB genes in 10-week-old NOD.CD45.2 mice, we found a signature of upregulated genes that predicted delayed or no diabetes. Major associated pathways included chromatin organization, cellular protein location and regulation of nitrogen compounds and RNA. In a clinical cohort, three of these genes were differentially expressed between first-degree relatives, T1D patients and controls. Bioinformatic analysis of differentially expressed genes in NOD.CD45.2 PB identified drugs that are predicted to delay or prevent diabetes. Of these drugs, 11 overlapped with drugs predicted to induce a human 'non-progressor' expression profile. These data demonstrate that disease heterogeneity in diabetes-prone mice can be exploited to mine novel clinical T1D biomarkers and drug targets.
authors.affiliation: Diamantina Institute, Translational Research Institute, University of Queensland , Woolloongabba, Queensland, Australia.
authors.forename: Dimeng
authors.initials: D
authors.lastname: Pang
authors.affiliation: Diamantina Institute, Translational Research Institute, University of Queensland , Woolloongabba, Queensland, Australia.
authors.forename: Katharine M
authors.initials: KM
authors.lastname: Irvine
authors.affiliation: Diamantina Institute, Translational Research Institute, University of Queensland , Woolloongabba, Queensland, Australia.
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Mehdi
authors.affiliation: St Vincent's Institute , Fitzroy, Victoria, Australia.
authors.forename: Helen E
authors.initials: HE
authors.lastname: Thomas
authors.affiliation: Department of Paediatric Endocrinology, Mater Health Services , South Brisbane, Queensland, Australia.
authors.forename: Mark
authors.initials: M
authors.lastname: Harris
authors.affiliation: Diamantina Institute, Translational Research Institute, University of Queensland , Woolloongabba, Queensland, Australia.
authors.forename: Emma E
authors.initials: EE
authors.lastname: Hamilton-Williams
authors.affiliation: Diamantina Institute, Translational Research Institute, University of Queensland , Woolloongabba, Queensland, Australia.
authors.forename: Ranjeny
authors.initials: R
authors.lastname: Thomas